Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Comprehensive, Quantitative Analysis of SRM 1950: the NIST Human Plasma Reference Material. [PDF]
Mandal R +9 more
europepmc +1 more source
Fundamental studies to develop certified reference material to calibrate spectrophotometer in the ultraviolet region [PDF]
F C da Conceição +2 more
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Is commutability of a reference material always desirable? [PDF]
Vogeser M, Habler K.
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Establishment of Reference Measurement Procedure for <i>TP53</i> R175H/R248W Detection and a Novel Preparation Method for ctDNA Reference Material. [PDF]
Tang Y, Niu C, Zhang J, Dong L, Yang J.
europepmc +1 more source
Biotite Reference Materials for Secondary Ion Mass Spectrometry 18O/16O Measurements
Guillaume Siron +4 more
openalex +2 more sources
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
SI-traceable characterisation of the first reference material for nanoparticle number concentration in suspension to support regulatory compliance. [PDF]
Bartczak D +8 more
europepmc +1 more source

